On the other hand, different tumor progression-related gene signatures were enriched in patients having low USF2-NuRD complex scores and high Metab-GS scores (Figure 6, Blue) suggesting that Metab-GS is associated with tumor aggressiveness and progression in bladder cancer. Here, USF2 is linked to urinary bladder carcinoma.